Separate Basic Region Motifs within the Adeno-Associated Virus Capsid Proteins Are Essential for Infectivity and Assembly
Open accessThe DOI matches its Crossref record; 71 of the 73 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) is gaining momentum as a gene therapy vector for human applications. However, there remain impediments to the development of this virus as a vector. One of these is the incomplete understanding of the biology of the virus, including nuclear targeting of the incoming virion during initial infection, as well as assembly of progeny virions from structural components in the nucleus. Toward this end, we have identified four basic regions (BR) on the AAV2 capsid that represent possible nuclear localization sequence (NLS) motifs. Mutagenesis of BR1 ( 120 QAKKRVL 126 ) and BR2 ( 140 PGKKRPV 146 ) had minor effects on viral infectivity (∼4- and ∼10-fold, respectively), whereas BR3 ( 166 PARKRLN 172 ) and BR4 ( 307 RPKRLN 312 ) were found to be essential for infectivity and virion assembly, respectively. Mutagenesis of BR3, which is located in Vp1 and Vp2 capsid proteins, does not interfere with viral production or trafficking of intact AAV capsids to the nuclear periphery but does inhibit transfer of encapsidated DNA into the nucleus. Substitution of the canine parvovirus NLS rescued the BR3 mutant to wild-type (wt) levels, supporting the role of an AAV NLS motif. In addition, rAAV2 containing a mutant form of BR3 in Vp1 and a wt BR3 in Vp2 was found to be infectious, suggesting that the function of BR3 is redundant between Vp1 and Vp2 and that Vp2 may play a role in infectivity. Mutagenesis of BR4 was found to inhibit virion assembly in the nucleus of transfected cells. This affect was not completely due to the inefficient nuclear import of capsid subunits based on Western blot analysis. In fact, aberrant capsid foci were observed in the cytoplasm of transfected cells, compared to the wild type, suggesting a defect in early viral assembly or trafficking. Using three-dimensional structural analysis, the lysine- and arginine-to-asparagine change disrupts hydrogen bonding between these basic residues and adjacent beta strand glutamine residues that may prevent assembly of intact virions. Taken together, these data support that the BR4 domain is essential for virion assembly. Each BR was also found to be conserved in serotypes 1 to 11, suggesting that these regions are significant and function similarly in each serotype. This study establishes the importance of two BR motifs on the AAV2 capsid that are essential for infectivity and virion assembly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AAV2 is the most extensively studied AAV serotype, including the functional characterization of all charged residues in the VP (Choi et al., 2005; Grieger et al., 2006; Lochrie et al., 2006; Mietzsch et al., 2019; Wang et al., 2019; Wu et al., 2000).”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Grieger et al., 2006
In the citing paper
“Previous mutagenesis and biophysical studies have reported the importance of some of these residues in virus assembly, production (Grieger et al., 2006; Wu et al., 2000), infectivity (Zhong et al., 2008), and pH-induced changes during trafficking (Nam et al., 2011; Salganik et al., 2012).”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Grieger et al., 2006
Citations
Cites
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Self-citationZolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Self-citationSequence requirements for nuclear location of simian virus 40 large-T antigen
Kalderon, D., Richardson, W. D., Markham, A. F., & Smith, A. E. (1984) · Nature · doi:10.1038/311033a0 · Cited by 1,286
Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus
Seisenberger, G., Ried, M. U., Endreß, T., Büning, H., Hallek, M., & Bräuchle, C. (2001) · Science · doi:10.1126/science.1064103 · Cited by 820
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Self-citationMicrotubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus
Sodeik, B., Ebersold, M. W., & Helenius, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1007 · Cited by 687
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
Bartlett, J. S., Wilcher, R., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2777-2785.2000 · Cited by 532 · cited 2×
“Evidence supporting both possibilities has been uncovered (1, 35, 48, 64).”
BackgroundSelf-citationA Viral Phospholipase A2 Is Required for Parvovirus Infectivity
Zádori, Z., Szelei, J., Lacoste, M.-C., Li, Y., Gariépy, S., Raymond, P., Allaire, M., Nabi, I. R., & Tijssen, P. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00031-4 · Cited by 518
Movement of a karyophilic protein through the nuclear pores of oocytes.
Feldherr, C. M., Kallenbach, E., & Schultz, N. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.6.2216 · Cited by 501
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Grieger, J. C., & Samulski, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9933-9944.2005 · Cited by 419
Self-citationEndosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8317 · Cited by 391
Wu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T., & Muzyczka, N. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8635-8647.2000 · Cited by 390
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
Kern, A., Schmidt, K., Leder, C., Müller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., & Kleinschmidt, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11072-11081.2003 · Cited by 380
Targeting of E. coli β-galactosidase to the nucleus in yeast
Hall, M. N., Hereford, L., & Herskowitz, I. (1984) · Cell · doi:10.1016/0092-8674(84)90055-2 · Cited by 374
Opie, S. R., Warrington, Agbandje-McKenna, M., Zolotukhin, S., & Muzyczka, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6995-7006.2003 · Cited by 364
Identification of PDGFR as a receptor for AAV-5 transduction
Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., & Chiorini, J. A. (2003) · Nature Medicine · doi:10.1038/nm929 · Cited by 355 · cited 1×
“7, step 1) (6, 26, 43, 52, 53) followed by clathrin-mediated”
Girod, A., Wobus, C. E., Zádori, Z., Ried, M., Leike, K., Tijssen, P., Kleinschmidt, J. A., & Hallek, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-973 · Cited by 354 · cited 2×
“As previously described ( 13 , 45), Vp3 only and Vp2/Vp3 virions were not infectious (Fig. 5Aii and 5Aiii) due to the lack of the phospholipase domain.”
MethodImport of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1
Trotman, L. C., Mosberger, N., Fornerod, M., Stidwill, R. P., & Greber, U. F. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1092 · Cited by 332
The role of the nuclear pore complex in adenovirus DNA entry
Greber, U. F., Suomalainen, M., Stidwill, R. P., Boucke, K., Ebersold, M. W., & Helenius, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5998 · Cited by 299
Ojala, P. M., Sodeik, B., Ebersold, M. W., Kutay, U., & Helenius, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4922-4931.2000 · Cited by 288
Douar, A.-M., Poulard, K., Stockholm, D., & Danos, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1824-1833.2001 · Cited by 282
Wobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 1×
“Based on structural studies, the putative NLS region (BR3) is located within the virion on the N terminus of Vp2 and Vp1 and therefore could not be used by an incoming virion to interact with the NPC transport machinery unless conformational changes took place first (28, 29, 61, 65).”
BackgroundSanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T., & Engelhardt, J. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9184-9196.2000 · Cited by 269
Intracellular trafficking of adeno-associated viral vectors
Ding, W., Zhang, L., Yan, Z., & Engelhardt, J. F. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302527 · Cited by 251
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246 · cited 1×
“7, step 1) (6, 26, 43, 52, 53) followed by clathrin-mediated”
Wurm, T., Chen, H., Hodgson, T., Britton, P., Brooks, G., & Hiscox, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9345-9356.2001 · Cited by 232
Role for highly regulated rep gene expression in adeno-associated virus vector production
Li, J., Samulski, R. J., & Xiao, X. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5236-5243.1997 · Cited by 227
Self-citationYan, Z., Zak, R., Luxton, G. W. G., Ritchie, T. C., Bantel-Schaal, U., & Engelhardt, J. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2043-2053.2002 · Cited by 222
Subcellular compartmentalization of adeno-associated virus type 2 assembly
Wistuba, A., Kern, A., Weger, S., Grimm, D., & Kleinschmidt, J. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1341-1352.1997 · Cited by 219
Whittaker, G. R., Kann, M., & Helenius, A. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.627 · Cited by 215
The Coronavirus Infectious Bronchitis Virus Nucleoprotein Localizes to the Nucleolus
Hiscox, J. A., Wurm, T., Wilson, L., Britton, P., Cavanagh, D., & Brooks, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.506-512.2001 · Cited by 214
Sorting in the endosomal system in yeast and animal cells
Lemmon, S. K., & Traub, L. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00117-4 · Cited by 209
Warrington, K. H., Gorbatyuk, O. S., Harrison, J. K., Opie, S. R., Zolotukhin, S., & Muzyczka, N. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6595-6609.2004 · Cited by 205
Bleker, S., Sonntag, F., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2528-2540.2005 · Cited by 200 · cited 2×
“It has been previously identified that Vp1 N termini can become surface exposed when capsids are heated, suggesting that this may be mimicking what is happening within the cell to expose the phospholipase domain of Vp1 (2, 4).”
BackgroundKronenberg, S., Böttcher, B., von der Lieth, C. W., Bleker, S., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5296-5303.2005 · Cited by 198 · cited 2×
“Based on structural studies, the putative NLS region (BR3) is located within the virion on the N terminus of Vp2 and Vp1 and therefore could not be used by an incoming virion to interact with the NPC transport machinery unless conformational changes took place first (28, 29, 61, 65).”
BackgroundDynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection
Duan, D., Li, Q., Kao, A. W., Yue, Y., Pessin, J. E., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10371-10376.1999 · Cited by 186
Production of Recombinant Adeno‐Associated Viral Vectors
Choi, V. W., Asokan, A., Haberman, R. A., & Samulski, R. J. (2007) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1209s53 · Cited by 171
Self-citationElectron cryo‐microscopy and image reconstruction of adeno‐associated virus type 2 empty capsids
Kronenberg, S., Kleinschmidt, J. A., & Böttcher, B. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve234 · Cited by 161 · cited 1×
“Based on structural studies, the putative NLS region (BR3) is located within the virion on the N terminus of Vp2 and Vp1 and therefore could not be used by an incoming virion to interact with the NPC transport machinery unless conformational changes took place first (28, 29 , 61, 65).”
BackgroundVihinen-Ranta, M., Wang, D., Weichert, W. S., & Parrish, C. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.4.1884-1891.2002 · Cited by 154
Lux, K., Goerlitz, N., Schlemminger, S., Perabo, L., Goldnau, D., Endell, J., Leike, K., Kofler, D. M., Finke, S., Hallek, M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11776-11787.2005 · Cited by 152
Hansen, J., Qing, K., Kwon, H.-J., Mah, C., & Srivastava, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.992-996.2000 · Cited by 147
Wistuba, A., Weger, S., Kern, A., & Kleinschmidt, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5311-5319.1995 · Cited by 147 · cited 2×
“Previous studies have established that AAV2 assembles in the nucleus in “intranuclear assembly centers” that increase in size over time as more capsid proteins enter and virions are assembled (23, 59, 60).”
BackgroundResultHaberman, R. P., McCown, T. J., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8732-8739.2000 · Cited by 139 · cited 1×
“Triple transfections with pACG2 (31), pTrufEGFP (16), and pXX6-80 (adeno-”
Self-citationYan, Z., Zak, R., Zhang, Y., Ding, W., Godwin, S., Munson, K., Peluso, R., & Engelhardt, J. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2863-2874.2004 · Cited by 138 · cited 1×
“7, steps 4 and 5) (7, 67) or facilitating down-”
BackgroundAdenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2
Xiao, W., Warrington, K. H., Hearing, P., Hughes, J., & Muzyczka, N. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11505-11517.2002 · Cited by 137
Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus
Rabinowitz, J. E., Xiao, W., & Samulski, R. J. (1999) · Virology · doi:10.1006/viro.1999.0045 · Cited by 136 · cited 1×
“As previously described (13, 45), Vp3 only and Vp2/Vp3 virions were not infectious (Fig.”
MethodSelf-citationHansen, J., Qing, K., & Srivastava, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4080-4090.2001 · Cited by 129
Adenovirus Protein V Induces Redistribution of Nucleolin and B23 from Nucleolus to Cytoplasm
Matthews, D. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.1031-1038.2001 · Cited by 123
Cotmore, S. F., D'Abramo, A. M., Ticknor, C. M., & Tattersall, P. (1999) · Virology · doi:10.1006/viro.1998.9520 · Cited by 121
Release of canine parvovirus from endocytic vesicles
Suikkanen, S., Antila, M., Jaatinen, A., Vihinen-Ranta, M., & Vuento, M. (2003) · Virology · doi:10.1016/j.virol.2003.08.031 · Cited by 115
Lombardo, E., Ramírez, J. C., Garcia, J., & Almendral, J. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7049-7059.2002 · Cited by 114
Lombardo, E., Ramírez, J. C., Agbandje-McKenna, M., & Almendral, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3804-3814.2000 · Cited by 101
Infection of Purified Nuclei by Adeno-associated Virus 2
Hansen, J., Qing, K., & Srivastava, A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0457 · Cited by 95
Matthews, D. A., & Russell, W. C. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-7-1671 · Cited by 94
The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein
Dundr, M., Leno, G. H., Hammarskjöld, M., Rekosh, D. M., Helga-Maria, C., & Olson, M. O. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.8.2811 · Cited by 93
Reguera, J., Carreira, A., Riolobos, L., Almendral, J. M., & Mateu, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307748101 · Cited by 90
Qiu, J., & Brown, K. E. (1999) · Virology · doi:10.1006/viro.1999.9664 · Cited by 86 · cited 1×
“It is noteworthy to mention that two studies have suggested that AAV virion assembly occurs in nucleoli utilizing indirect immunofluorescence for nucleolin (44) and an unspecified nucleolar protein (59).”
BackgroundHoque, M., Ishizu, K.-I., Matsumoto, A., Han, S.-I., Arisaka, F., Takayama, M., Suzuki, K., Kato, K., Kanda, T., Watanabe, H., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7912-7915.1999 · Cited by 70
Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells
Hunter, L. A., & Samulski, R. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.317-324.1992 · Cited by 68
Self-citationCarreira, A., Menéndez, M., Reguera, J., Almendral, J. M., & Mateu, M. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307662200 · Cited by 68 · cited 1×
“Specifically, it has been shown that MVM and CPV virions expose their NLS-containing Vp1 N termini in vitro upon exposure to mild heating or low pH without disassembly, mimicking what might be occurring within the cell, presumably in the endosome (3, 4, 46, 51, 56).”
BackgroundCharacterization of a Nuclear Localization Signal of Canine Parvovirus Capsid Proteins
Vihinen‐Ranta, M., Kakkola, L., Kalela, A., Vilja, P., & Vuento, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0389a.x · Cited by 60
The Nucleolus Is the Site of Borna Disease Virus RNA Transcription and Replication
Pyper, J. M., Clements, J. E., & Zink, M. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7697-7702.1998 · Cited by 57
MacLean, C. A., Rixon, F. J., & Marsden, H. S. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-7-1921 · Cited by 55
Four Casein Kinase I Isoforms Are Differentially Partitioned between Nucleus and Cytoplasm
Fu, Z., Chakraborti, T., Morse, S., Bennett, G. S., & Shaw, G. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5324 · Cited by 49
Nucleoplasmic and nucleolar distribution of the adenovirus IVa2 gene product
Lutz, P. G., Puvion-dutilleul, F., Lutz, Y., & Kédinger, C. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3449-3460.1996 · Cited by 47
Ryabov, E. V., Kim, S. H., & Taliansky, M. E. (2004) · Journal of General Virology · doi:10.1099/vir.0.79854-0 · Cited by 45
Puvion-Dutilleul, F., & Christensen, M. E. (1993) · PubMed · Cited by 40
Production of Recombinant Adeno‐Associated Viral Vectors
Haberman, R. A., Kroner‐Lux, G., & Samulski, R. J. (1999) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1209s23 · Cited by 7
Self-citation
Research works printed but not linked: 1
- Hunter L. A. 1992. Ph.D. thesis. University of Pittsburgh Pittsburgh Pa.
Cited by
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
Samulski, R. J., & Muzyczka, N. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085355 · Cited by 551
Self-citationGene therapy for neurological disorders: progress and prospects
Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.110 · Cited by 306
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
Zinn, E., Pacouret, S., Khaychuk, V., Turunen, H. T., Carvalho, L. S., Andres-Mateos, E., Shah, S., Shelke, R., Maurer, A. C., Plovie, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.019 · Cited by 310
“, 2000), phospholipase activity and nuclear localization activity on VP1,2 unique domains (Girod et al., 2002; Grieger et al., 2006), a limited number of docking sites for monoclonal antibodies (DiMattia et al.”
BackgroundSonntag, F., Bleker, S., Leuchs, B., Fischer, R., & Kleinschmidt, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.01056-06 · Cited by 280
“Very recently, further evidence has been presented that BC3 acts in nuclear transport of AAV genomes, based on a difference in nuclear accumulation of recombinant AAV genomes packaged into wt or BC3 mutant capsids shown by in situ hybridization (24).”
BackgroundBalfour, H. H., Sifakis, F., Sliman, J. A., Knight, J. A., Schmeling, D. O., & Thomas, W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit321 · Cited by 266
“Western Blot Assay Serum specimens with discordant EIA and IFA results were tested by Western blot using the method described by Grieger et al [23] and optimized for EBV as follows.”
Method
Metadata
- Authors
- Grieger, J. C., Snowdy, S., & Samulski, R. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Curriculum in Genetics and Molecular Biology
- Corresponding author
- Samulski, Richard J.
- ORCID
- Samulski, Richard J.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-06
- Volume
- 80
- Issue
- 11
- Pages
- 5199-5210
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2002565864
- Cited by
- 172
- References
- 73
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 18 · 2023: 8 · 2022: 8 · 2021: 9 · 2020: 10 · 2019: 13 · 2018: 10 · 2017: 8 · 2016: 5 · 2015: 12 · 2014: 8 · 2013: 11 · 2012: 10
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (5p01gm059299-10, DK-34987, DK065988)
- University of North Carolina at Chapel Hill
- National Heart, Lung, and Blood Institute (P01HL051818, P01HL066973)
- National Institute of General Medical Sciences (5P01 GM 059299, P01 GM-059299)
- National Institute of Diabetes and Digestive and Kidney Diseases (5P30 DK 34987, P30DK034987, P30DK065988)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Infectious Diseases › Parvovirus B19 Infection Studies
- Keywords
- adeno-associated virus, nuclear localization signal, viral infectivity, viral assembly, VP1, VP2, DNA encapsidation, capsid structure, gene therapy vectors, hydrogen bonding
- MeSH terms
- Dependovirus, Capsid, HeLa Cells, Humans, Virus Assembly, Amino Acid Motifs, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.